Manufacturer for Benzalkonium Chloride Cold Sore - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex
Manufacturer for Benzalkonium Chloride Cold Sore - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Detail:
Product Detail
|
NO. |
Products |
CAS No. |
Application |
Key Quality Indicator |
||||
|
Purity |
Isomer |
SI * |
Max * |
Moisture |
||||
|
1 |
Fmoc-Lys(Mtt)-OH | 167393-62-6 | Lysine side chain modification |
≥99.0% |
≤0.1% |
≤0.2% |
≤0.3% |
≤1.0% |
|
2 |
Fmoc-Lys(Alloc)-OH | 146982-27-6 | Lysine side chain modification |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
3 |
Fmoc-Lys(ivDde)-OH | 150629-67-7 | Lysine side chain modification |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
4 |
Fmoc-Lys(Mmt)-OH | 159857-60-0 | Lysine side chain modification |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
5 |
Fmoc-Glu-OtBu | 84793-07-7 | LiraglutideSemaglutide |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
6 |
Glu-OtBu | 45120-30-7 | LiraglutideSemaglutide |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
7 |
Octadecanedioic acid | 871-70-5 | Semaglutide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
8 |
Octadecanedioic acid mono-tert-butyl ester | 843666-40-0 | Semaglutide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
9 |
tBu-OOC-C16-CO-Glu-OtBu | 1188328-39-3 | SemaglutideFragment A |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
10 |
AEEA | 134978-97-5 | SemaglutideAlbuvirtide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
11 |
AEEA-OH.HCl | 134979-01-4 | SemaglutideAlbuvirtide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
12 |
Fmoc-AEEA-OH | 166108-71-0 | SemaglutideAlbuvirtide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
13 |
Boc-AEEA-OH | 108466-89-3 | Semaglutide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
14 |
AEEA-AEEA | 1143516-05-5 | Semaglutide |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
15 |
Fmoc-AEEA-AEEA-OH | 560088-89-3 | SemaglutideFragment B |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
16 |
Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH | 1118767-16-0 | SemaglutideFragment C |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
17 |
tBu-OOC-C16-CO-Glu(AEEA-AEEA-NHS)-OtBu | 1118767-15-9 | SemaglutideFragment D |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
18 |
Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH | 1662688-20-1 | Semaglutide Fragment E |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
19 |
Boc-His(Trt)-OH | 32926-43-5 | The end is histidine |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤4.0% |
|
20 |
Fmoc-Aib-OH | 94744-50-0 | Semaglutide |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
21 |
Boc-His(Trt)-Aib-OH | 2061897-68-3 | Semaglutide |
≥99.0% |
≤0.1% |
≤0.2% |
≤0.3% |
≤2.0% |
|
22 |
Fmoc-Glu(OtBu)-Gly-OH | 866044-63-5 | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
23 |
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH | 1169630-31-2？ | Semaglutide Fragment F |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
24 |
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS | 1169630-40-3 | Semaglutide Fragment G |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
25 |
Fmoc-Arg(pbf)-Gly-OH | 660846-80-0 | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
26 |
Fmoc-Ala-Ala-OH | 87512-31-0 | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
27 |
Fmoc-Thr(tBu)-Phe-OH | 1260609-75-3 ? | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
28 |
Palmitic acid | 1957/10/3 | Liraglutide Fragment 1 |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
29 |
Palm-Glu-OtBu | NA | Liraglutide Fragment 2 |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
30 |
Palm-Glu(NES)-OtBu | NA | Liraglutide Fragment 3 |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
31 |
Fmoc-Lys(Palm-Glu-OtBu)-OH | 1491158-62-3 | Liraglutide |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
32 |
Hexadecanedioic acid | 505-54-4 | Insulin degludec |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
33 |
Hexadecanedioic acid mono-tert-butyl ester | 843666-27-3 | Insulin degludec |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
34 |
tBu-OOC-C14-CO-Glu-OtBu | NA | Insulin degludec Fragment I |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
35 |
tBu-OOC-C14-CO-Glu(NES)-OtBu | NA | Insulin degludec Fragment II |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
SI *= Specific Impurity
Max*= Max Unknown Impurity
Other Indicator:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
Sanitization
Sanitization of distribution system, including loop and storage tank is performed by Pasteurization. When Pasteurization sanitization is performed, the purified water in tank is heated up to 80°C and start to circulate by distribution system. The sanitization lasts 1 hour after reaching 80°C. Sanitization is performed every quarter. The purified water system sanitization logbook was checked with no excursion highlighted.
Product detail pictures:
Related Product Guide:
Dedicated to strict high-quality management and considerate purchaser support, our experienced employees members are usually available to discuss your specifications and be certain full shopper satisfaction for Manufacturer for Benzalkonium Chloride Cold Sore - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex , The product will supply to all over the world, such as: Colombia, Jamaica, Zurich, We will not only continuously introduce technical guidance of experts from both home and abroad, but also develop the new and advanced products constantly to satisfactorily meet the needs of our clients all over the world.
By April from Azerbaijan - 2017.04.28 15:45
The company comply with the contract strict, a very reputable manufacturers, worthy a long-term cooperation.
By Polly from azerbaijan - 2018.06.21 17:11
